SOPHiA GENETICS to Announce Financial Results for the Fourth Quarter and Full Year of Fiscal 2022 on March 7, 2023
February 23 2023 - 4:40PM
Business Wire
SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company
in the healthcare space, today announced it will release its
financial results for the fourth quarter and full year of fiscal
2022 before U.S. markets open on Tuesday, March 7, 2023. SOPHiA
GENETICS will host a conference call to discuss its financial
results as well as business outlook beginning at 8:00 a.m. EST /
2:00 p.m. CET.
The call will be webcast live on the SOPHiA GENETICS Investor
Relations website. Additionally, a replay will be available on the
website after its completion.
About SOPHiA GENETICS
SOPHiA GENETICS (Nasdaq: SOPH) is a software company dedicated
to establishing the practice of data-driven medicine as the
standard of care and for life sciences research. It is the creator
of the SOPHiA DDM™ Platform, a cloud-native platform capable of
analyzing data and generating insights from complex multimodal data
sets and different diagnostic modalities. The SOPHiA DDM™ Platform
and related solutions, products and services are currently used by
a broad network of hospital, laboratory, and biopharma institutions
globally. For more information, visit SOPHiAGENETICS.COM, or
connect on Twitter, LinkedIn, Facebook, and Instagram.
Where others see data, we see answers.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230223005992/en/
Investor: Katherine Bailon VP, Investor Relations
ir@sophiagenetics.com
Media: Nick Puleo npuleo@comsint.com
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From May 2024 to Jun 2024
Sophia Genetics (NASDAQ:SOPH)
Historical Stock Chart
From Jun 2023 to Jun 2024